Another investigation has reported that PACAP was significantly capable of de-escalating the programmed cell death and easing the conversion of cellular demise from the late to early phase in a rotenone-prompted cellular PD model [205]. This evidence concerns the gene ADCYAP1 and Parkinson disease.